Dr. Joyce Suhy is an accomplished professional with over 30 years of experience in both operational and scientific aspects of the medical imaging field across several therapeutic areas and leads Clario’s Medical Imaging division. She has significant expertise in the field of Neuroscience and since 2001, Dr. Suhy has been at the forefront of designing and scientifically overseeing Neuroscience clinical trials that incorporate imaging endpoints. Notably, she and her team’s extensive imaging knowledge and experience have been instrumental in the development of the first and second Alzheimer’s disease-modifying drugs to receive FDA approval. Dr. Suhy holds a Ph.D. in Biochemistry, complemented by fellowship training in Neuroradiology. This multidisciplinary training equips her with comprehensive understanding of underlying biological processes and advanced imaging techniques having led to her authoring numerous scientific journal articles and other scientific publications. Recognized for her contributions to the field, Dr. Suhy is frequently invited to participate in expert panels aimed at advancing the use of imaging in clinical trials. Her dedication and expertise have earned her recognition, including being named one of PharmaVoice’s 100 Most Inspiring People in the Life-Science Industry in 2020. With extensive experience, scientific acumen and leadership prowess, Dr. Suhy continues to drive advancements within the Medical Imaging business at Clario.